Skip to main content
. 2016 Mar 25;51(1):23–30. doi: 10.5045/br.2016.51.1.23

Table 3. Summary of treatment in seven PPCL and two SPCL patients.

graphic file with name br-51-23-i003.jpg

a)Not affordable for bortezomib.

Note: Among ten PPCLs, one lost follow-up before start of therapy and two opted against therapy. Out of four SPCLs, two opted against therapy.

Abbreviations: PPCL, primary plasma cell leukemia; SPCL, secondary plasma cell leukemia; CR, complete response; PR, partial response; sCR, stringent CR.